OncoStrong™
Lung Cancer
PreclinicalActive
Key Facts
About Lamark Biotech
Thermostable biologics platform that makes insulin, AMD and cancer therapies affordable without refrigeration.
View full company profileTherapeutic Areas
Other Lung Cancer Drugs
| Drug | Company | Phase |
|---|---|---|
| 15dPMJ2 | Claradele Pharmaceuticals | Research |
| SUPLEXA | Alloplex Biotherapeutics | Phase 1 |
| Oncology Digital Biomarkers | Imvaria | Development |
| Aerosolized Platinum Nanoparticles | HylaPharm | Pre-clinical |
| ENV105 | Kairos Pharma | Phase 1 |
| AI for Lung Cancer | Invenio Imaging | Research |
| Liposome Program | NanoTech Pharma | Preclinical/Phase 1/2 |
| Dendritic Cell Vaccine | MegaNano BioTech | Pre-clinical |
| AI Biomarkers for Lung Cancer | BioAI Health | Unknown |
| PRDM2 Target | ARIZ Precision Medicine | Preclinical |
| ZEN-3694 | Zenith Epigenetics | Proof-of-Concept |
| TEC-001 + Keytruda | Teclison | Phase 2 |